Symbiosis Pharma specialise in biological manufacturing and biologics fill finish. If you are responsible for the development of a biopharmaceutical drug product, such as ATMPs and peptide therapeutics, then your project may require an outsourced partner that can convert your precious biological drug substance into a sterile final drug product.
Given Symbiosis’ experience in supporting multiple clients from around the world who have this specific challenge, we believe we are perfectly placed to successfully deliver on this kind of project requirement.
Clean Room Facilities
Operating within dedicated cleanroom facilities at our GMP MHRA-licensed facility in Scotland, our experienced team routinely fill biological products such as:
- Antibodies and recombinant proteins
- ATMPs, including viral vectors, oncolytic viruses and plasmids
- Viral vaccines
- RNA, DNA and peptide therapeutics
- Antibody-drug conjugates (ADCs)
- Cytotoxic, cytostatic and highly potent APIs
Our small-scale capability enables us to fill bulk volumes under 100 litres per batch, including products that require aseptic liquid filling and specialist lyophilization. This biological sterile manufacturing capability can accommodate drug product supply requirements for clinical trials and low volume commercial supply.
Due to the complex nature of sterile manufacturing of biological drug products, quality, regulatory compliance, and the highest levels of technical capability are at the heart of the service we provide for every project we undertake.
As an agile CMO, we are also flexible in terms of offering our biotech and specialty pharmaceutical clients rapid access to manufacturing slots, fast QA batch release and a quicker route to clinic.
If you are planning a biological sterile manufacturing project, or want to find out more about our biological manufacturing services, then please contact our team today. If your deadline is tight, then ask our team about available manufacturing slots.